What's the recommended sequence mmr or cosentyx?

Why should the MMR vaccine come before starting Cosentyx?
The MMR shot contains live attenuated viruses. When a patient is on an immunosuppressant such as the IL‑17 blocker Cosentyx, the immune system is weakened, increasing the risk of a serious reaction to a live vaccine. CDC guidance says live vaccines are contraindicated in patients receiving biologics until the drug has been stopped for at least four weeks or the patient has recovered adequate immunity [1][2].

When can a patient safely receive the MMR shot?
The CDC recommends that MMR be given at least four weeks before a biologic is started. If the patient is already on Cosentyx, the MMR should not be administered; instead, inactivated vaccines should be used until the biologic is discontinued and the immune response has recovered [1][3].

What if the patient has already started Cosentyx?
Once treatment has begun, live vaccines are generally avoided. If an MMR‑like protection is needed, clinicians may consider a booster with a non‑live alternative—though no such alternative exists for measles, mumps, or rubella. The safest option is to wait until the biologic is stopped or the immune system has recovered sufficiently, then administer MMR [4].

Can other vaccines replace MMR while on Cosentyx?
No licensed inactivated vaccine covers measles, mumps, or rubella. However, inactivated influenza, pneumococcal, and hepatitis B vaccines can be safely given while on Cosentyx. These provide protection against other common infections without the risk of live‑vaccine complications [5].

What risks arise if MMR is given while on Cosentyx?
The primary risk is vaccine‑associated disease: the weakened immune system may fail to contain the attenuated virus, potentially causing a full‑blown measles or rubella infection. Serious adverse events have been reported in immunocompromised patients who received live vaccines [6].

How long after stopping Cosentyx should MMR be administered?
CDC and dermatology guidelines suggest waiting at least four weeks after discontinuation of biologics before giving live vaccines, but a longer interval may be prudent if the patient has had recent severe immunosuppression or if the vaccine schedule requires a delayed booster [7].

Summary
Give the MMR vaccine before starting Cosentyx. If Cosentyx is already in use, postpone live vaccines until the drug is stopped and the immune system has recovered, and rely on inactivated vaccines for the interim.

Sources
[1] https://www.cdc.gov/vaccines/vac-gen/contraind.html
[2] https://www.cdc.gov/vaccines/cp/clinical-considerations/immunocompromised.html
[3] https://www.aaaai.org/education-and-advocacy/patient-education/clinical-guidelines
[4] https://www.fda.gov/drugs/postmarket-drug-safety-information-patients-and-providers/secukinumab-pregnancy
[5] https://www.cdc.gov/flu/prevent/flu-vaccine.html
[6] https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4282325/
[7] https://www.medscape.com/viewarticle/786583_2